Hunt joins the company from HeartBeam.

The agency differentiates between software that has a notable impact on the effectiveness and safety of drug use.

Korean-based company HoneyNaps developed the algorithm.

The device, Maverick, utilizes Raman spectroscopy for bioprocess control.

The decision will not impact the device’s FDA clearance for other indications.

The system will be part of a NPH study.

The results are published in "Critical Care," an international journal focused on intensive care medicine.

Dreem 3S to implement electroencephalogram data from the brain to monitor sleep architecture.

S-Patch Ex designed to record heart rate both at home and in a clinical setting.

Proceeds expected to help company drive several initiatives, including enhancements to its ultraportable peritoneal dialysis system.

Limaca Medical’s device had previously received a breakthrough device designation from FDA.

The device used a headset with a virtual display to provide information to surgeons during procedures.

The device provides surgeons with GPS-like guidance.

This will allow the product to arrive in hospitals at a faster pace.

Opportunity still exists despite market conditions.

The technology, created by IceCure Medical, freezes tumors and is an alternative to surgical intervention.

OnPoint, a group of privately held AR companies, will present the platform.

Abid Rahman and Mike DeLuca discuss developing the AI-powered chatbot.

The device is described as a motor-robotic prosthetic knee.

Arkell discusses the need to democratize AI for the healthcare industry.

AcuityMD’s CEO speaks about the current market and how its impacting smaller medical device companies.

The company also announced a new automation facility to be located in Shanghai.

The FDA granted 501(k) clearance to Fresenius’ Versi HD with GUideMe Software. The device will be available in select markets at some point in 2023, and previous models will be upgradeable.

The CEO spoke about recent mergers and testing for Alzheimer’s.

Research and Market’s report also says that the medical animation market will grow by a CGAR of 19.9% in the next decade.

The MARS platform combines magnets and machinery.

The device, developed by magAssist, is an interventional ventricular assistance device.

The virtual health and remote care company is partnering with BioIntelliSense and Stel Life.

Art Medical’s CEO Liron Elia explains the importance of enteral nutrition in ICU patient care.

A new report details the factors expected to drive the market’s growth in the coming years.